dacarbazine has been researched along with Cancer, Second Primary in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (20.93) | 18.2507 |
2000's | 28 (32.56) | 29.6817 |
2010's | 33 (38.37) | 24.3611 |
2020's | 7 (8.14) | 2.80 |
Authors | Studies |
---|---|
Googe, PB; Li, H; McKenna, EF; Moschos, SJ; Pergaris, A; Theocharis, S; Yan, Y | 1 |
Hagelstein, V; Klee, G; Kurzhals, JK; Langan, EA; Terheyden, P; Zillikens, D | 1 |
Cutter, DJ; Daly, P; Duane, FK; Gillham, C; Houlihan, OA; McArdle, O; Ntentas, G | 1 |
Bloudek, B; Burke, JM; Fanale, M; Liu, N; Migliaccio-Walle, K; Phillips, T; Yu, KS | 1 |
Charpentier, C; Dreno, B; Flet, L; Fronteau, C; Guile, R; Khammari, A; Nguyen, JM; Poinas, A; Riche, VP; Thomare, P; Varey, É | 1 |
André, MPE; Bellei, M; Brice, P; Brière, J; Carde, P; Casasnovas, O; Clément-Filliatre, L; Depaus, J; Douxfils, J; Dupuis, J; Federico, M; Fortpied, C; Gianni, AM; Gobbi, PG; Heczko, M; Hutchings, M; Iannitto, E; Mounier, N; Rambaldi, A; Valagussa, P; Viviani, S; Zinzani, PL | 1 |
Cui, F; Yan, J; Zhao, S | 1 |
Borchmann, P; Borchmann, S; Bröckelmann, PJ; Buerkle, C; Diehl, V; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Müller, H; Plütschow, A; Sasse, S | 1 |
Becker, I; Eichenauer, DA; Engert, A; Franklin, J; Monsef, I | 1 |
Miyakita, Y; Momota, H; Narita, Y; Shibui, S | 1 |
Bartlett, NL | 1 |
Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB | 1 |
Hochhaus, A; Kunert, C; Schnetzke, U; Scholl, S; Schrenk, K; Spies-Weisshart, B | 1 |
Dieckmann, K; Kluge, R; Körholz, D; Mauz-Körholz, C; Vordermark, D | 1 |
Bochenek-Cibor, J; Krupa, M; Moskała, M; Trojanowski, T | 1 |
Bayman, E; Gilson, D; Murray, L; Prestwich, RJ; Robertshaw, H; Sethugavalar, B; Thomas, E | 1 |
Beaven, AW; Diehl, LF; Kelsey, CR; Kim, GJ; Prosnitz, LR; Torok, JA; Wu, Y | 1 |
Almagro-Casado, E; Cantos, B; Pérez-Callejo, D; Provencio, M; Salas, C; Sánchez, A | 1 |
Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A | 1 |
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
Ajit, NE; Burton, GV; El-Osta, H; Peddi, P | 1 |
Campanelli, M; Caputo, MD; Del Poeta, G; Foà, R; Frustaci, AM; Galieni, P; Gentile, M; Gozzetti, A; Guarini, A; Innocenti, I; Laurenti, L; Mauro, FR; Morabito, F; Motta, M; Murru, R; Raponi, S; Reda, G; Tedeschi, A | 1 |
Camci, C; Comez, G; Kalender, ME; Pehlivan, Y; Sari, I; Sevinc, A | 1 |
Bourgeois, JM; Hodson, I; Macdonald, P; Midia, M; Mullah-Ali, A; Portwine, C; Ramsay, JA | 1 |
Cordera, S; Joosens, E; Nader, P; Neyns, B; Pouratian, N | 1 |
Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA | 1 |
Davies, SM; Geiger, H; Weiss, B | 1 |
Das, P; Dwary, A; Goyal, S; Gupta, D; Mohanti, BK; Muzumder, S; Sharma, A; Thulkar, S | 1 |
Nishikawa, R | 1 |
Leong, C; Lim, ST; Loh, Y; Ngeow, J; Quek, R; Tan, HC; Tan, I; Tao, M | 1 |
Cheson, BD | 1 |
de Juan, M; Díaz, R; Fonfría, M; Mancheño, N; Moral, P; Tormo, A | 1 |
Hosono, A; Makimoto, A; Miyakita, Y; Momota, H; Nariata, Y; Narita, Y; Shibui, S | 1 |
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M | 1 |
Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O | 1 |
Chen, DB; Shen, DH; Wang, Y | 1 |
Fukushima, T; Inoue, T; Kawaguchi, H; Komatsu, F; Komatsu, M; Nabeshima, K; Oshiro, S; Tsugu, H | 1 |
Ichikawa, M; Kurokawa, M; Nakamura, F; Nannya, Y; Ogura, M; Tanaka, M; Todo, T | 1 |
Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D | 1 |
Chen, BE; Connors, JM; Crump, M; Dar, AR; Djurfeldt, MS; Gospodarowicz, MK; Horning, SJ; Meyer, RM; Pearcey, RG; Shepherd, LE; Shustik, C; Stewart, DA; Wells, WA; Winter, JN | 1 |
Abo-Madyan, Y; Giordano, FA; Welzel, G; Wenz, F | 1 |
Hoshimaru, M; Kawanabe, Y; Kihara, S; Koizumi, T; Sasaki, N; Sawada, M; Ueda, S; Yukawa, H | 1 |
Abasq, C; Charles-Pétillon, F; Coat, C; De Braekeleer, M; Marcorelles, P; Quintin-Roué, I; Talagas, M; Uguen, A | 1 |
Hewer, E; Kappeler, A; Reinert, MM; Vajtai, I; Vassella, E | 1 |
Goto, Y; Hashimoto, N; Kagawa, N; Khoo, HM; Kinoshita, M; Kishima, H; Maruno, M; Yoshimine, T | 1 |
Chim, CS; Choi, PT; Lee, WK | 1 |
Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA | 1 |
Dixit, S; Hingorani, M; Rajaraman, C; Rowland-Hill, C; Salvage, D | 1 |
Bardier, A; Blot, E; Decaudin, D; Pouillart, P; Veyradier, A; Zagame, OL | 1 |
Diehl, V; Dörken, B; Dühmke, E; Franklin, J; Hasenclever, D; Herrmann, R; Lathan, B; Loeffler, M; Müller-Hermelink, HK; Paulus, U; Pfreundschuh, M; Tesch, H | 1 |
Longo, DL | 1 |
Belhaj Ali, Z; Benna, F; Besbes, M; Bouaouina, N; Boussen, H; Gammoudi, A; Ghilen, L; Kochbati, L; Maalej, M; Rahal, K | 1 |
Anargyrou, K; Angelopoulou, MK; Boussiotis, VA; Boutsis, DE; Dimopoulou, MN; Karkantaris, C; Kokoris, SI; Kontopidou, FN; Kyrtsonis, MC; Michalopoulos, T; Panayiotidis, P; Pangalis, GA; Papavassiliou, C; Siakantaris, MP; Tsaftaridis, P; Variamis, E; Vassilakopoulos, TP | 1 |
Bonadonna, G; Bonfante, V; Gianni, AM; Valagussa, P; Viviani, S | 1 |
Bouffet, E; Foreman, N; Korones, DN; Smith, A | 1 |
Alpert, TE; Hatoum, GF; Morbidini-Gaffney, S; Sagerman, RH | 1 |
Baehring, J; Ballen, KK; Berliner, N; Henson, JW; Kracher, J; Lacy, J; Noronha, V | 1 |
Connors, JM; Foltz, LM; Song, KW | 1 |
Arora, B; Biswas, G; Deshmukh, C; Khadwal, A; Kurkure, PA; Shetty, V | 1 |
Arcaini, L; Baio, A; Brusamolino, E; Casagrande, W; Franchini, P; Griva, V; Lazzarino, M; Orlandi, E; Pascutto, C; Passamonti, F | 1 |
Doherty, LM; Drappatz, J; Kesari, S; Monje, ML; Ramakrishna, NR; Wen, PY; Young, G | 1 |
Diehl, V; Fuchs, M | 1 |
Beard, J; Elmahy, H; Hawley, I | 1 |
Bouffet, E; Fukushima, S; Katsuki, H; Shigemori, M; Terasaki, M | 1 |
Crippa, C; Facchetti, F; Ferrari, S; Frata, P; Grazioli, L; Magrini, SM; Pizzocaro, C; Re, A; Rossi, G; Tucci, A | 1 |
Alessandrino, EP; Astori, C; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Livraghi, A; Morra, E; Orlandi, E; Pagnucco, G | 1 |
Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R | 1 |
Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G | 1 |
Prosnitz, LR; Wu, JJ; Yahalom, J | 1 |
Cooper, DL; Levy, A; Salloum, E; Tallini, G | 1 |
Goldberg, SL; Klumpp, TR; Mangan, KF; Ming, PL; Mullaney, MT; Rao, PN; Redei, I | 1 |
André, M; Brice, P; Cazals, D; Fermé, C; Gisselbrecht, C; Hennequin, C; Kerneis, Y; Lepage, E; Rousselot, P; Zini, JM | 1 |
Behrendt, H; van den Berg, H; Zsiros, J | 1 |
Andrieu, JM; Colonna, P | 1 |
Aviles, A; Delgado, S | 1 |
Acevedo, A; Arranz, R; Fernández-Rañada, JM; Gil-Fernández, JJ; Muñoz, E; Sobrino, MP | 1 |
Joensuu, H; Muhonen, T; Nyandoto, P | 1 |
Bonadonna, G; Valagussa, P | 1 |
Aisenberg, AC | 1 |
Calvo Villas, J; Ramírez Sánchez, M; Sicilia Guillén, F | 1 |
Bosković, D; Colović, M; Elezović, I; Tomin, D | 1 |
el Omri, H; Ennabli, S; Korbi, S; Kraiem, I; Skouri, H; Sriha, B; Youssef, YB | 1 |
Ebsen, M; Kirchner, EM; Kirchner, J; Theegarten, D; Voigtmann, R | 1 |
Arnott, S; D'Ardenne, J; Ganesan, TS; Lister, TA; Oza, A; Perry, N; Shand, WS; Stansfeld, AG; Wrigley, PF | 1 |
Kiss, A; Rák, K; Telek, B; Ujj, G | 1 |
Bruce-Gregorios, JH; Feun, LG; Green, B; Nadeem, SQ | 1 |
14 review(s) available for dacarbazine and Cancer, Second Primary
Article | Year |
---|---|
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine; Young Adult | 2020 |
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Vinblastine | 2017 |
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2013 |
Astrocytoma malignum in glioblastoma multiforme vertens with long term survival--case report and a literature review.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Craniotomy; Dacarbazine; Frontal Lobe; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Prognosis; Remission Induction; Temozolomide | 2014 |
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lumbar Vertebrae; Mechlorethamine; Muscle Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Oncogene Proteins, Fusion; Remission Induction; Retroperitoneal Neoplasms; Sarcoma, Synovial; Spinal Stenosis; Translocation, Genetic; Vincristine | 2008 |
[Treatment of glioma with temozolomide].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Dacarbazine; DNA Damage; Glioblastoma; Humans; Leukemia, Myeloid, Acute; Lomustine; Myelodysplastic Syndromes; Neoplasms, Second Primary; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide | 2009 |
Is BEACOPP better than ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Forecasting; Hodgkin Disease; Humans; Infertility; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Patient Selection; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Temozolomide may induce therapy-related acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Glioma; Humans; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide | 2011 |
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature.
Topics: Aged; Breast Neoplasms; Dacarbazine; Female; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide | 2006 |
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Heart Diseases; Hodgkin Disease; Humans; Infertility; Lung Diseases; Mechlorethamine; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Survival Rate; Vinblastine; Vincristine | 2007 |
The case for adjuvant radiation therapy in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Vinblastine | 1996 |
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine | 1996 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prednisone; Procarbazine; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Salvage Therapy; Spain; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1998 |
Problems in Hodgkin's disease management.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cardiomyopathies; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infections; Laparotomy; Lung Diseases, Interstitial; Lymphography; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiation Injuries; Radiotherapy; Remission Induction; Salvage Therapy; Vinblastine; Vincristine | 1999 |
16 trial(s) available for dacarbazine and Cancer, Second Primary
Article | Year |
---|---|
Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
Topics: Dacarbazine; Humans; Ki-67 Antigen; Lymphocytes, Tumor-Infiltrating; Melanoma; Neoplasms, Second Primary; Prognosis; Retrospective Studies; Vemurafenib | 2022 |
Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Neoplasms, Second Primary; United States; Vinblastine | 2023 |
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Survival Rate; Time Factors; Vinblastine; Vincristine; Young Adult | 2017 |
Secondary hematological malignancies associated with temozolomide in patients with glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Female; Follow-Up Studies; Glioma; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Retrospective Studies; Temozolomide; Young Adult | 2013 |
Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiation Injuries; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult | 2014 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Radiotherapy; Survival Analysis; Treatment Outcome; Vinblastine | 2012 |
ABVD vs. radiotherapy in early stage Hodgkin's lymphoma: A critical look at the NCIC HD.6 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Chemoradiotherapy; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Lymphatic Irradiation; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Risk Factors; United States; Vinblastine | 2012 |
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine | 2003 |
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Neoplasms, Second Primary; Pilot Projects; Temozolomide; Treatment Outcome | 2008 |
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Combined Modality Therapy; Dacarbazine; Disease Management; Disease-Free Survival; Doxorubicin; Female; Gallium; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Risk; Tomography, X-Ray Computed; Vinblastine | 2008 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine | 1994 |
Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Gonads; Heart; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prospective Studies; Radiotherapy; Survival Rate; Thyroid Gland; Treatment Outcome; Vinblastine; Vindesine | 1997 |
Treatment of childhood Hodgkin's disease without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine | 1997 |
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasms, Second Primary; Oligospermia; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1998 |
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Life Tables; Lymphoma; Neoplasms, Second Primary; Nervous System Diseases; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine | 1998 |
56 other study(ies) available for dacarbazine and Cancer, Second Primary
Article | Year |
---|---|
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Immune Checkpoint Inhibitors; Male; Melanoma; Neoplasms, Second Primary; Retrospective Studies; Skin Neoplasms; Tumor Microenvironment | 2022 |
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breath Holding; Cardiovascular Diseases; Dacarbazine; Doxorubicin; Female; Heart; Hodgkin Disease; Humans; Lymphoma; Mediastinal Neoplasms; Neoplasms, Second Primary; Organs at Risk; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Vinblastine | 2023 |
Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
Topics: Cost-Benefit Analysis; Cost-Effectiveness Analysis; Dacarbazine; Female; Humans; Male; Melanoma; Neoplasms, Second Primary; Retrospective Studies | 2023 |
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine | 2022 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Databases, Factual; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Poisson Distribution; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Survivors; Thyroid Neoplasms; Vinblastine; Vincristine; Young Adult | 2014 |
Different clones of acute leukemia after successful treatment of Hodgkin's disease.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Azacitidine; Bleomycin; Bone Marrow; Clone Cells; Consolidation Chemotherapy; Dacarbazine; Doxorubicin; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Acute; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Palliative Care; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Vinblastine | 2014 |
Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Humans; Lymphatic Irradiation; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Organs at Risk; Radiotherapy; Radiotherapy Dosage; Risk Assessment; Vinblastine; Young Adult | 2015 |
Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Hypothyroidism; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiotherapy Dosage; Retrospective Studies; Vinblastine; Young Adult | 2015 |
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Vinblastine; Vincristine; Young Adult | 2016 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2016 |
Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cognition Disorders; Dacarbazine; Dexamethasone; Glioblastoma; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary; Piracetam; Temozolomide | 2016 |
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine | 2017 |
Synchronous Hodgkin's disease and gastric adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Radiography; Reed-Sternberg Cells; Stomach Neoplasms; Treatment Outcome; Vinblastine | 2007 |
Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Glioma; Humans; Lymphoma, Non-Hodgkin; Mice; Middle Aged; Neoplasms, Second Primary; Risk Assessment; Temozolomide | 2008 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hodgkin Disease; Hospitals, Urban; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Vinblastine; Vincristine; Young Adult | 2009 |
Possible leukemogenic potential of temozolomide.
Topics: Animals; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Dacarbazine; DNA; Mice; Mice, Transgenic; Mutation; Neoplasms, Second Primary; Polymerase Chain Reaction; Temozolomide | 2009 |
Non-Hodgkin lymphoma following temozolomide.
Topics: Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Glioblastoma; Humans; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Temozolomide | 2009 |
Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Vinblastine | 2010 |
Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy.
Topics: Adenocarcinoma, Follicular; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Female; Humans; Hypertension; Immunotherapy; Interferons; Melanoma; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Thyroid Neoplasms | 2010 |
Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Child; Dacarbazine; Female; Frontal Lobe; Genes, p53; Germ-Line Mutation; Humans; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide | 2010 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hyperparathyroidism, Primary; Male; Mechlorethamine; Neoplasms, Second Primary; Parathyroid Neoplasms; Prednisone; Procarbazine; Vinblastine; Vincristine | 2010 |
[Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD79 Antigens; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Second Primary; Prednisone; Rituximab; Vinblastine; Vincristine | 2010 |
Radiation-induced astrocytoma with rapid malignant transformation: case report.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Basal Ganglia; Brain Neoplasms; Cell Transformation, Neoplastic; Cerebellar Neoplasms; Dacarbazine; Fatal Outcome; Gait Disorders, Neurologic; Humans; Hydrocephalus; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide; Time Factors; Young Adult | 2011 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Node Excision; Mastectomy, Segmental; Mechlorethamine; Mediastinum; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2012 |
Radiation-induced spinal cord anaplastic astrocytoma subsequent to radiotherapy for testicular seminoma.
Topics: Antineoplastic Agents; Astrocytoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease Progression; Fatal Outcome; Humans; Hydrocephalus; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Nimustine; Seminoma; Spinal Cord Compression; Spinal Cord Neoplasms; Syringomyelia; Temozolomide; Testicular Neoplasms; Thoracic Vertebrae; Time Factors | 2012 |
[A silent-growing and fast-killing melanoma in a teenager].
Topics: Adolescent; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Back Pain; Combined Modality Therapy; Cyclin D1; Dacarbazine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gene Amplification; Head and Neck Neoplasms; Humans; Immunotherapy; In Situ Hybridization, Fluorescence; Ipilimumab; Lymphatic Metastasis; Melanoma; Nausea; Neoplasm Proteins; Neoplasms, Second Primary; Nevus; Osteolysis; Scalp; Skin Neoplasms; Weight Loss | 2012 |
Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; Disease Progression; Gliosarcoma; Humans; Isocitrate Dehydrogenase; Male; Mutation; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide | 2012 |
Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Cerebellar Neoplasms; Dacarbazine; Ependymoma; Female; Humans; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide | 2013 |
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Combined Modality Therapy; Dacarbazine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Salvage Therapy; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vincristine | 2013 |
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; California; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dacarbazine; Databases, Factual; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Melphalan; Methotrexate; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Risk; Vinblastine; Vincristine | 2013 |
Hypernatremia-associated myelinolysis following the management of sepsis in a patient with glioblastoma treated with radiotherapy and temozolomide.
Topics: Antineoplastic Agents; Brain Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Dacarbazine; Diabetes Mellitus; Fatal Outcome; Glioblastoma; Humans; Hypernatremia; Hypertension; Liver Diseases; Male; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Conformal; Sepsis; Temozolomide; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2013 |
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; CA-19-9 Antigen; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Ifosfamide; Jaundice; Metalloendopeptidases; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paraneoplastic Syndromes; Sarcoma; Thrombocytopenia; von Willebrand Factor | 2002 |
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Incidence; Mechlorethamine; Menopause, Premature; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Vinblastine; Vincristine | 2003 |
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Tunisia; Vinblastine; Vincristine | 2003 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disease Progression; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vinblastine; Vincristine | 2005 |
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Etoposide; Female; Glioma; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome | 2006 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Goiter, Nodular; Hodgkin Disease; Humans; Mechlorethamine; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neurilemmoma; Pleural Neoplasms; Prednisone; Procarbazine; Radiotherapy; Recurrence; Skin Neoplasms; Vinblastine; Vincristine | 2005 |
Hodgkin's lymphoma in adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Mechlorethamine; Medical Record Linkage; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Registries; Risk Assessment; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2006 |
Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Dacarbazine; Dose Fractionation, Radiation; Doxorubicin; Femur; Hodgkin Disease; Humans; Male; Mediastinum; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive; Vinblastine | 2006 |
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fertility; Follow-Up Studies; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Pregnancy; Radiotherapy, Adjuvant; Survival Analysis; Vinblastine | 2006 |
Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Dacarbazine; Diagnosis, Differential; Female; Glioma; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiotherapy; Temozolomide | 2007 |
Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Cells; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Lymphocytes; Lymphocytosis; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasms, Second Primary; Splenectomy; Splenic Neoplasms; Splenomegaly; Vinblastine | 2007 |
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Multivariate Analysis; Myocardial Infarction; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Prospective Studies; Radiotherapy; Regression Analysis; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Patient Compliance; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Chromosome Deletion; Chromosomes, Human, Pair 20; Clone Cells; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Hematopoietic Cell Growth Factors; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm, Residual; Neoplasms, Second Primary; Neoplastic Stem Cells; Prednisone; Procarbazine; Radiotherapy; Recurrence; Transplantation, Autologous; Vinblastine; Vincristine | 1997 |
Second cancer among long-term survivors from Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Survivors; Time Factors; Vinblastine; Vincristine | 1998 |
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Susceptibility; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Mechlorethamine; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Splenectomy; Vinblastine; Vincristine; Whole-Body Irradiation | 1998 |
[Chronic lymphatic leukemia and Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasms, Second Primary; Prednisone; Remission Induction; Vidarabine; Vinblastine | 1999 |
Pregnancy after treatment of secondary acute promyelocytic leukemia following Hodgkin's disease: a case report.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Pregnancy; Pregnancy Outcome; Treatment Outcome; Tretinoin; Vinblastine | 2000 |
[Gastric adenocarcinoma secondary to Hodgkin's disease treatment].
Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Deglutition Disorders; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Stomach Neoplasms; Tomography, X-Ray Computed; Vinblastine; Weight Loss | 2001 |
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Remission Induction; Rituximab; Vinblastine; Vincristine | 2001 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymphatic Diseases; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1992 |
[Secondary acute leukemia in Hodgkin's disease].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vinblastine; Vincristine | 1992 |
Post radiation sarcoma (malignant fibrous histiocytoma) of the cervical spine following ependymoma (a case report).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Cervical Vertebrae; Combined Modality Therapy; Dacarbazine; Dexamethasone; Diagnostic Errors; Doxorubicin; Ependymoma; Histiocytoma, Benign Fibrous; Humans; Laminectomy; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, High-Energy; Spinal Cord Neoplasms; Spinal Neoplasms | 1991 |